Search Results for: Research
MenaQ7® has been the pioneering force in the world of Vitamin K2, recognized for its clinically proven benefits to support bone and cardiovascular health, which created the K2 category. And still, there is more to come with MenaQ7®. The success of the MenaQ7® story and its proven health effects across life stages has spurred unprecedented interest in … Continue reading A New Look for a New Era of Vitamin K2 – Enjoy Our New Video
MenaQ7® has been the pioneering force in the world of Vitamin K2, recognized for its clinically proven benefits to support bone and cardiovascular health, which created the K2 category. And still, there is more to come with MenaQ7®.
The success of the MenaQ7® story and its proven health effects across life stages has spurred unprecedented interest in this little but powerful molecule.Today, the importance of Vitamin K2 is more crucial than ever, and its future is burning bright.
Expanding Our Understanding of Vitamin K2
As research advances, it becomes increasingly important to explore the expanding role of Vitamin K2 in supporting various aspects of health. At Gnosis, we now look beyond K2’s proven benefits of bone and heart health, and with that step-change, the time has come to redefine the MenaQ7® brand identity to align with this aspiration for new discovery and validation.
The magnifying glass element of the new logo represents the brand’s curious spirit. The color change signifies the commitment to natural processes that leave minimal impact on the environment.
The new brand identity should serve as a reminder that MenaQ7® is a tool for transforming lives through science-backed, natural solutions. Simply put, MenaQ7® is the K2 for brands that aspire for more. We invite you to experience the brand’s evolution for yourself.
> Watch the Video Now
Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2. Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as … Continue reading Experience the New MenaQ7 K2 Brand Identity
Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2.
Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as a brand has remained relatively unchanged for the past 14 years, with a keen focus on validated benefits for bone health in children and adults and cardiovascular health in adults. But in acquiring MenaQ7® in 2021, Gnosis recognized the growing potential of Vitamin K2 for more areas of health, marking the perfect time to introduce the new MenaQ7® Natural Vitamin K2 as MK-7.
“The foundation of clinical evidence using MenaQ7® is what built the Vitamin K2 category and shaped our understanding of this important nutrient as we know it today. We believe the brand has signified ‘Quality Confirmed by Science,’ which is why so many of our partners include the logo on their product labels, marketing collateral, and websites,” says Marc Philouze, Gnosis by Lesaffre General Manager. “Yet research is beckoning the continuation of that pioneering spirit, and more work must be done to confirm Vitamin K2’s expanding role in supporting other areas of health. To that end, we have decided to introduce a new logo and brand identity for this new journey.”
New Elements
Customers and the industry can expect no change in the core tenants of MenaQ7®: Science, Expertise, and Support. These pillars will anchor the brand on this new path of innovation, according to Philouze, which led to the “magnifying glass” component of the logo.
“The magnifying glass speaks to the curious spirit of discovery, and that quality and science must be meticulously sought,” he continues. “Curiosity is essential to usher Vitamin K2 into the future – illuminating new indications with technological innovations unlocking new consumer applications.”
Other new elements are the logo’s colors and tagline. The new logo emphasizes Gnosis’s dedication to natural processes that leave minimal environmental impact. To that end, the colors are softened and reversed from the traditional dark blue with a light green accent. And where MenaQ7® has long been “Vitamin K2 as MK-7,” the MenaQ7 logo tagline is now “Natural Vitamin K2 as MK-7.”
“The visual identity introduced today has been designed to better connect with our customers and the industry, and represent the work we do, utilizing what nature has to offer and the protection of our planet’s resources,” concludes Philouze. “As we look to the future, we see nothing but promise and potential, particularly as the benefits of Vitamin K2 are expanding. Here, again, we will lead in that discovery with MenaQ7®.”
The new brand identity is reflected on the refreshed www.MenaQ7.com and will make the transition to quality finished products featuring MenaQ7®.
>_______
About Gnosis by Lesaffre
Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.
Gnosis by Lesaffre – Exploring Life to Improve Living. http://www.GnosisByLesaffre.com
About Lesaffre
A key global player in fermentation for more than a century, Lesaffre, with a 2.2-billion-euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe fermentation is one of the most promising answers to this challenge.
Lesaffre – Working together to better nourish and protect the planet.
In honor of the CDC’s recognition of February as “Heart Month,” the Council for Responsible Nutrition (CRN) highlighted the health care cost savings potential of four nutrient categories. The CRN report notes all four ingredient categories — omega-3 fatty acids, magnesium, vitamin K2, and soluble fibers — have significant research backing, so much so … Continue reading Heart-Healthy Ingredients Can Spell Big Savings : CRN Report
In honor of the CDC’s recognition of February as “Heart Month,” the Council for Responsible Nutrition (CRN) highlighted the health care cost savings potential of four nutrient categories.
The CRN report notes all four ingredient categories — omega-3 fatty acids, magnesium, vitamin K2, and soluble fibers — have significant research backing, so much so that three of them have achieved FDA-approved qualified health claims. While considered a « latecomer ,» the report notes persuasive evidence is piling up for the vitamin K2’s effects in suppressing the development of arterial plaques. The mechanism of action has been shown to be the activation of the bone-building protein osteocalcin, which serves to maintain calcium in the bones and keep levels in the blood down to healthy amounts.
Curious what the health care cost savings could be?
The report assigns the specific yearly potential in the 2022 to 2030 timeframe.
Vitamin K deficiency is common among kidney transplant recipients (KTR) and likely contributes to progressive vascular calcification and stiffness. Vitamin K2’s proven cardiovascular support makes it a nutrient for consideration. MenaQ7 has been the source material for more than 22 published human clinical trials confirming safe and efficacious heart and bone benefits. Some of … Continue reading Vitamin K2’s Kidney Health Potential
Vitamin K deficiency is common among kidney transplant recipients (KTR) and likely contributes to progressive vascular calcification and stiffness. Vitamin K2’s proven cardiovascular support makes it a nutrient for consideration.
MenaQ7 has been the source material for more than 22 published human clinical trials confirming safe and efficacious heart and bone benefits. Some of those trials examined the positive impact of K2 supplementation in patients with compromised kidney health as those patients expressed intense calcification as a symptom of their condition.
According to the researchers of a new trial published in the American Journal of Transplantation, «in this randomized, double-blind, placebo-controlled clinical trial, vitamin K- supplementation did not alter serum calcification propensity, but ‘inhibited’ progression of arterial stiffness in KTR, suggesting that vitamin K may have vascular effects independent of serum calcification propensity. These results provide a basis for long-term intervention studies with vitamin K2-supplementation in KTR. »
Gnosis by Lesaffre finds these results promising, picking up on some of the important work that started with MenaQ7 Vitamin K2 as MK-7. Westenfeld et al. published a standout randomized controlled trial in 2013, that confirmed most hemodialysis patients have a functional vitamin K deficiency, and that K2 supplementation (as MenaQ7) induced a dose- and time-dependent decrease in circulating inactive Matrix Gla Protein (MGP) and Osteocalcin, the K-dependent proteins that support heart and bone health, respectively.
As March is National Kidney Month, we hope to shine a light on this important work showing the potential of a natural vitamin. And we will continue to drive discovery through scientific research.
MenaQ7 science has confirmed that Vitamin K2 simultaneously supports bone and heart health. But did you know that research also points to an important link between K2 and kidney health? We invite you to enjoy a new eBook that highlights Vitamin K2’s unique ability to help the body to properly utilize calcium, as well … Continue reading Vitamin K2 Health Benefits : New eBook
MenaQ7 science has confirmed that Vitamin K2 simultaneously supports bone and heart health. But did you know that research also points to an important link between K2 and kidney health?
We invite you to enjoy a new eBook that highlights Vitamin K2’s unique ability to help the body to properly utilize calcium, as well as detailing the groundbreaking science that shows MenaQ7 K2 supports bone health (in adults and children), and cardiovascular and kidney health (in adults).
Gnosis enriches its research advisory board to reflect existing clinical partnerships exploring new indications, advancing the potential for the K2 category. Gnosis by Lesaffre, the leading K2 supplier with the most and best clinically validated Vitamin K2 as MK-7, MenaQ7®, has enjoyed long-standing relationships with the world’s most renowned researchers. Today, the company announces … Continue reading Gnosis Expands Long-Standing Vitamin K2 Scientific Advisory Committee
Gnosis enriches its research advisory board to reflect existing clinical partnerships exploring new indications, advancing the potential for the K2 category.
Gnosis by Lesaffre, the leading K2 supplier with the most and best clinically validated Vitamin K2 as MK-7, MenaQ7®, has enjoyed long-standing relationships with the world’s most renowned researchers. Today, the company announces it is enhancing its Scientific Advisory Committee to highlight its commitment to exploring new indications while also identifying an expanding global presence of top thought leaders in biomedical research focused on Vitamin K2.
The Vitamin K2 Scientific Advisory Committee plays an integral role in program conceptualization, strategic development, and scientific advisory research regarding Vitamin K2. This group of esteemed, independent experts represents diverse geographic origins, helping Gnosis to identify specific population needs across the globe, offering a wide range of expertise and unique perspectives around K2. This, in turn, will return more robust opportunities for our finished product partners to create more impactful products for the market.
The Committee is chaired by the undisputed expert in Vitamin K2 research, Dr. Leon Schurgers, a Full Professor of Biochemistry of Vascular Calcification, Vice-Chair of Biochemistry at the Cardiovascular Research Institute Maastricht (CARIM), and chair of the stem cell research university Maastricht (SCRUM), Maastricht University (the Netherlands). He is also scientific advisor of the steering scientific board on the worldwide quality assurance plan for vitamin K detection, a member of the scientific advisory board of the Dutch Thrombosis Society, and author of more than 240 research papers in the international scientific press.
The Gnosis Vitamin K2 Scientific Advisory Committee was established based on the long-term, historical collaboration between Dr. Schurgers and Gnosis (previously NattoPharma). “No one has been a bigger proponent elucidating the benefits of vitamin K, and in particular K2 than Dr. Schurgers, as well as citing the absolute need for a K2-specific recommended daily intake (RDI),” says Jean-Francois Jeanne, Substantiation & Applications Team Manager. “Further, Gnosis has supported Research Teams worldwide, which has led to many new insights from clinical studies, including those identifying new clinical indications for K2, and combinations for K2, such as NOACs or Omega-3. This has ushered in an increased awareness of Vitamin K2’s potential grounded in science.”
“The collaboration between Gnosis and our research group at Maastricht University has led to many ground- breaking studies, including two PhD students that have defended their work at Maastricht University,” Schurgers says. “Further, Gnosis (previously NattoPharma) was a partner in EU Horizon 2020 innovative training programs, in which Maastricht University was beneficiary or coordinator. This clearly shows the scientific commitment of Gnosis.”
The Members of the Committee include:
• Hogne Vik, MD, PhD, MBA: A physician by education, Dr. Vik has served as a clinician, researcher, and Professor in Medicine at the University of Bergen, Norway. He is the author of more than 100 international research papers and has the last 25 years especially been interested in exploring health benefits associated with regular intake of vitamin K2 and omega-3 fatty acids. He has a successful scientific and commercial track record around these substances both within the pharmaceutical and dietary supplement industries. As previous CEO and Chief Medical Officer with NattoPharma ASA, he now serves as a medical and scientific advisor at Gnosis by Lesaffre.
• Katarzyna Maresz, PhD: Vitamin K2 scientific expert, Dr. Maresz is the former President of the International Science and Health Foundation, an independent research consortium dedicated to educating about the clinically validated benefits of nutrients, and the former Scientific Coordinator of the educational portal VitaminK2.org. She has published more than 30 scientific papers and is involved in Vitamin K2 clinical trials worldwide, cooperating with many research centers regarding the health effects and mechanism of action of Vitamin K2.
“I am honored to be invited into the Gnosis by Lesaffre Vitamin K2 Scientific Committee and look very much forward to continuing the scientific collaboration with Leon Schurgers and Katarzyna Maresz,” says Dr. Vik. “An assessment of available new biological data and documented clinical health benefits for vitamin K2 are, in my opinion, the best way to collect and communicate trustful information that will help people to understand why a regular intake of this vitamin is beneficial for health and quality of life.”
Gnosis by Lesaffre looks forward to announcing additional members in the immediate future. The group will be enlarged by those who have been collaborating with Gnosis for many years as well as new research partners to provide more visibility and ignite the passion for Vitamin K2.
“As the leader in the Vitamin K2 category, it is essential that we continue to drive the discovery of new indications and understanding, for benefit of our partners making the products that will shape a healthier global population,” says Marc Philouze, Gnosis by Lesaffre General Manager. “Our Scientific Advisory Committee has been at the forefront of that discovery, and their input will be essential to feed and continue in the delivery of the highest quality in science proposed by more than 70 Research & Application scientists working at Gnosis. It is our honor and obligation to enhance their potential for success.”
_______
About Gnosis by Lesaffre
Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.
About Lesaffre
A key global player in fermentation for more than a century, Lesaffre, with a 2.2 billion euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe fermentation is one of the most promising answers to this challenge.
Lesaffre – Working together to better nourish and protect the planet.